Adaptogens as potential drugs for prevention of infectious diseases

S. Vershinina, K. V. Yaremenko
{"title":"Adaptogens as potential drugs for prevention of infectious diseases","authors":"S. Vershinina, K. V. Yaremenko","doi":"10.17816/rcf20199-104","DOIUrl":null,"url":null,"abstract":"The work is devoted to the analysis of scientific research on the prevention of infectious diseases by adaptogens, proposed by a prominent domestic toxicologist and pharmacologist Professor Nikolai Vasilyevich Lazarev and the school of scientists he created. The role of adaptogens (dibazol, Eleutherococcus, Rhodiola rosea, Scutellaria Baicalensis) in creating a state of non-specifically increased body resistance (NSIBR according to N.V. Lazarev) for the prevention of viral diseases, including coronavirus infection, was evaluated. Analysis of the pharmacological properties of the synthetic adaptogen bendazol (dibazol) opened by N.V. Lazarev, showed that the drug has a number of positive properties: antiviral stimulates immunity to the attack of infectious agents, being an inducer of endogenous interferon; antiproliferative inhibits the replication of viruses inside the host cell; immunomodulatory corrects violations of the protective functions of the body. Dibazol also has a mild effect after vaccination, stimulating the production of immunoglobulins. These properties of dibazol make it possible to recommend it and herbal adaptogens (tinctures of Eleutherococcus, Rhodiola rosea, Scutellaria Baicalensis) for the prevention of coronavirus infection.","PeriodicalId":21186,"journal":{"name":"Reviews on Clinical Pharmacology and Drug Therapy","volume":"58 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews on Clinical Pharmacology and Drug Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17816/rcf20199-104","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

The work is devoted to the analysis of scientific research on the prevention of infectious diseases by adaptogens, proposed by a prominent domestic toxicologist and pharmacologist Professor Nikolai Vasilyevich Lazarev and the school of scientists he created. The role of adaptogens (dibazol, Eleutherococcus, Rhodiola rosea, Scutellaria Baicalensis) in creating a state of non-specifically increased body resistance (NSIBR according to N.V. Lazarev) for the prevention of viral diseases, including coronavirus infection, was evaluated. Analysis of the pharmacological properties of the synthetic adaptogen bendazol (dibazol) opened by N.V. Lazarev, showed that the drug has a number of positive properties: antiviral stimulates immunity to the attack of infectious agents, being an inducer of endogenous interferon; antiproliferative inhibits the replication of viruses inside the host cell; immunomodulatory corrects violations of the protective functions of the body. Dibazol also has a mild effect after vaccination, stimulating the production of immunoglobulins. These properties of dibazol make it possible to recommend it and herbal adaptogens (tinctures of Eleutherococcus, Rhodiola rosea, Scutellaria Baicalensis) for the prevention of coronavirus infection.
适应原作为预防传染病的潜在药物
这项工作致力于分析由国内著名毒理学家和药理学家尼古拉·瓦西里耶维奇·拉扎列夫教授及其创立的科学家学派提出的利用适应原预防传染病的科学研究。对适应原(双巴唑、棘球绦虫、红景天、黄芩)在预防包括冠状病毒感染在内的病毒性疾病中产生非特异性增强的机体抵抗力(N.V. Lazarev称NSIBR)的作用进行了评估。N.V. Lazarev对合成适应原苯达唑(dibazol)的药理学性质进行了分析,结果表明该药物具有许多积极的特性:抗病毒刺激免疫抵抗感染因子的攻击,是内源性干扰素的诱导剂;抗增殖抑制宿主细胞内病毒的复制;免疫调节纠正违反身体的保护功能。双巴唑在接种疫苗后也有轻微的作用,刺激免疫球蛋白的产生。双巴唑的这些特性使它有可能与草药适应原(刺红球菌、红景天、黄芩酊剂)一起用于预防冠状病毒感染。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.50
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信